ABSTRACT Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated considerable efficacy in the treatment of diabetes and obesity, it is essential to recognize that their use is associated with certain intrinsic risks that must not be disregarded
Cigna said providing "financial predictability" through a cost cap will allow health plans and employers to better plan to manage GLP-1 spending
A few things that may help: Try eating earlier in the evening (at least 34 hours before sleep) Keep meals lighter, especially at night Avoid lying down right after eating Elevate your head slightly during sleep Stay well hydrated throughout the day From a microbiome perspective, combining Akkermansia with butyrate-producing support (such as Clostridium butyricum) can sometimes improve gut motility and reduce irritation over time
five units of one may contain twice as much drug as the other
For someone using or considering GLP-1s (or wanting to avoid them), supplementing with high-quality, whole-food nutrients can help fill the gaps: ensuring adequate micronutrient intake, supporting GI health, maintaining lean mass, supporting metabolic regulation, and perhaps reducing reliance on medication by optimizing physiology
Within the first seven days, you'll feel your body begin to reset*
